Navigation Links
Ben-Gurion University of the Negev receives $450,000 grant to conduct oil and natural gas research
Date:8/8/2012

BEER-SHEVA, ISRAEL, August 8, 2012 Ben-Gurion University of the Negev (BGU) researchers have received a $450,000 grant (290,000) from the Wolfson Family Charitable Trust and Wolfson Foundation for projects related to oil and gas generation and its environmental impact.

According to BGU's Vice President for Research and Development Prof. Moti Herskowitz, these two projects are part of the University's overall commitment to research alternative energy sources and cleaner technologies. "This support reflects BGU's leadership role in alternative energy research in Israel thanks to its multidisciplinary approach," says Herskowitz, who is also the founder and director of the BGU Blechner Center for Industrial Catalysis and Process Development.

One of the grant projects being conducted at the Blechner Center is focused on using a novel method for conversion of natural gas to syngas through catalytic partial oxidation for downstream treatment of natural gas. The researchers believe that this process provides significant opportunities for commercial production.

The other project involves tracking oil and gas formation in a variety of environments, source rocks and generation mechanisms, through the investigation of sulfur and short hydrocarbon transformations using molecular and isotopic geochemical approach. The research will be conducted by BGU's Department of Geology and Environmental Sciences to help improve the understanding of oil and gas generation and their environmental impact.

"BGU has a worldwide reputation for its research and innovation in alternative energy, and now, this grant will further Israel's position in reducing worldwide reliance on oil, as part of the BGU energy initiative," says Doron Krakow, executive vice president of American Associates, Ben-Gurion University of the Negev.


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. Sleep deprivation may reduce risk of PTSD according to Ben-Gurion U. researchers
3. University of Houston study shows BP oil spill hurt marshes, but recovery possible
4. University of Alberta led research may have discovered how memories are encoded in our brains
5. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
6. Marshall University study may lead to new treatments for prostate cancer
7. University leads £6 million EU project to tackle obesity
8. A University of Tennessee professors hypothesis may be game changer for evolutionary theory
9. Life expectancy may affect when you get married, divorced, have kids: Queens University study
10. University of Toronto biologists predict extinction for organisms with poor quality genes
11. University of Minnesota invention helps advance reliability of alternative energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)...  It is gratifying to see that the Obama ... science as a means to better understand human biology, ... was honored to participate in today,s White House event ... Since the 1980s my teams have been ... sequenced genome of a free living organism, the first ...
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ... in general the State of Washington,s ... a new enrollment and central issuance system for driver,s licenses ... The project planning and development will start in January ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Valid USA Signs Contract For Washington Driver's License Issuance 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... Researchers with Lawrence Berkeley National Laboratory (Berkeley Lab) ... U.S Department of Homeland Security (DHS) in conjunction ... determine how airborne contaminants would spread if released ... is now underway and runs from December 5-11, ...
... Though they remain a leading killer, heart attacks ... diagnosed following initial onset of symptoms. In a study ... , researchers have identified cardiac myosin-binding protein C (cMyBP-C) ... one that may be particularly valuable for mild attacks ...
... Kingdom, December, 2009 Newly published research, by investigators, ... in the journal Stem Cells reported the ... Cell Deficiency" (LSCD) using the patients, own stem cells ... LSCD is a painful, blinding disease that ...
Cached Biology News:Berkeley Lab researchers participate in Homeland Security study of subway airflow 2Potential new heart attack biomarker uncovered 2Successful stem cell therapy for treatment of eye disease 2
(Date:3/4/2015)... DUBLIN , Mar. 04, 2015 Research ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report ... a characteristic that can be objectively measured and ... pathogenic processes as well as pharmacological responses to ...
(Date:3/4/2015)... 4, 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) (the ... a collaborative research program with Emerald Logic, ... Collective Evolution Technology (FACET), Emerald Logic analyzed ... obtained from each of 798 patients who ... trials ASSERT, SUSTAIN and ASSURE. The objective ...
(Date:3/4/2015)... 04, 2015 Proove Biosciences ... Medicine, is excited to announce the launch of ... Optimize the Management of Pain”. , The continuing ... for the next year. The focus of the ... recognize inadequate pain treatments, integrate appropriate pain management ...
(Date:3/4/2015)... Pa. , March 4, 2015 /PRNewswire/ ... services and technology provider, today announced that ... 10 countries convened at its annual European ... to discuss the use of ... challenges. BioClinica,s eClinical technologies include: the Microsoft ...
Breaking Biology Technology:Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3
... (NYSE: DGX ), the nation,s leading provider ... is scheduled to speak,at the Lehman Brothers Eleventh ... at The Loews Miami Beach Hotel, Miami, Florida.,The ... 9:00 a.m.,Eastern Time., The presentation will be ...
... DIEGO, March 14 NuVasive, Inc. (Nasdaq:,NUVA), a medical ... treatments for the spine, announced today,that Kevin O,Boyle, Executive ... at the Lehman Brothers Eleventh Annual Global,Healthcare Conference at ... on,Wednesday, March 19, 2008 at 10:15 a.m. ET., ...
... webcast live and archived on Company,s web site, ... (Nasdaq: MBRK ), a pharmaceutical company focused ... Dr. Edward M. Rudnic, MiddleBrook president and CEO, ... 2008, at 4:45 p.m.,Eastern Time., The presentation ...
Cached Biology Technology:Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference 2
... 0-10 psi precision pressure regulator and pressurized ... Faster liquid-switching Steady flow rate ... delivery Can be added to any ... Scientific, any third-party manufacturer, even homemade. Connect to ...
...
Chicken polyclonal to UCK2 ( Abpromise for all tested applications). Antigen: Full length protein, corresponding to amino acids 1-261 of Human UCK2 Entrez Gene ID: 7371 Swiss Protein ID: ...
... (rEK) is a highly purified preparation of ... serine protease which recognizes the identical cleavage ... has similar enzymatic activity. Novagen&'s enzyme is ... purified to yield the highest activity available, ...
Biology Products: